# US 2011/0300223 A1 · Immunogenic composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0300223 A1
- Document ID: US20110300223A1
- Status: Published application
- Kind: A1
- Application number: 13/202,336
- Filed: 2010-02-26
- Published: 2011-12-08
- Earliest claimed: 2009-02-27
- Assignees: Toray Industries, Inc.
- Inventors: Reiji Nishio; Nobuo Ida
- Web page: https://patentgrep.com/patent/US20110300223A1

## CPC

- A61K 39/39: characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61K 47/60: the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- A61K 47/61: the organic macromolecular compound being a polysaccharide or a derivative thereof
- A61P 37/04: Immunostimulants
- A61K 2039/545: {characterised by the dose, timing or administration schedule}
- A61K 2039/55555: {Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers}
- A61K 2039/6025: {Nucleotides}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An immunogenic composition includes as an effective ingredient an antigen-adjuvant microparticle complex containing an antigen encapsulated in an adjuvant microparticle composed of an amphiphilic polymer(s) whose hydrophobic segment is a poly(hydroxy acid), or a particle composed of the antigen-adjuvant microparticle complex associated together, can induce a high immune response against the antigen even with a small amount of the antigen and a small number of doses, so that the immunogenic composition is useful as a vaccine effective for therapy and prophylaxis of infectious diseases, cancer and the like.

## Claims

### Claim 1

An immunogenic composition comprising as an effective ingredient an antigen-adjuvant microparticle complex containing an antigen encapsulated in an adjuvant microparticle composed of an amphiphilic polymer(s) comprising a poly(hydroxyl acid) hydrophobic segment and a polysaccharide hydrophilic segment.

### Claim 2 (depends on 1)

The immunogenic composition according to claim 1, comprising as an effective ingredient a particle composed of said antigen-adjuvant microparticle complex associated together.

### Claim 3 (depends on 1)

The immunogenic composition according to claim 1, wherein said adjuvant microparticle has a hydrophilic portion in the inside thereof, said hydrophilic portion being composed of a hydrophilic segment of said amphiphilic polymer, and has an outer layer composed of a hydrophobic portion constituted by said hydrophobic segment of said amphiphilic polymer.

### Claim 4

(canceled)

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The immunogenic composition according to claim 1, wherein said polysaccharide is dextran.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The immunogenic composition according to claim 1, wherein said poly(hydroxy acid) is a poly(lactic-co-glycolic acid).

### Claim 9 (depends on 1)

The immunogenic composition according to claim 1, further comprising a surface modifier bound to said poly(hydroxy acid) of said adjuvant microparticle.

### Claim 10 (depends on 1)

The immunogenic composition according to claim 1, wherein the average particle size of said antigen-adjuvant microparticle complex or said particle composed of said antigen-adjuvant microparticle complex associated together is 0.1 to 50 μm.

### Claim 11 (depends on 1)

The immunogenic composition according to claim 1, further comprising an immune-activating substance as an effective ingredient.

### Claim 12 (depends on 11)

The immunogenic composition according to claim 11, wherein said immune-activating substance is a nucleic acid.

### Claim 13 (depends on 11)

The immunogenic composition according to claim 11, wherein said immune-activating substance is CpG.

### Claim 14 (depends on 12)

The immunogenic composition according to claim 12, wherein said immune-activating substance is CpG.

### Claim 15 (depends on 2)

The immunogenic composition according to claim 2, wherein said adjuvant microparticle has a hydrophilic portion in the inside thereof, said hydrophilic portion being composed of a hydrophilic segment of said amphiphilic polymer, and has an outer layer composed of a hydrophobic portion constituted by said hydrophobic segment of said amphiphilic polymer.

### Claim 16 (depends on 2)

The immunogenic composition according to claim 2, wherein said poly(hydroxy acid) is a poly(lactic-co-glycolic acid).

### Claim 17 (depends on 3)

The immunogenic composition according to claim 3, wherein said poly(hydroxy acid) is a poly(lactic-co-glycolic acid).

### Claim 18 (depends on 6)

The immunogenic composition according to claim 6, wherein said poly(hydroxy acid) is a poly(lactic-co-glycolic acid).

### Claim 19 (depends on 2)

The immunogenic composition according to claim 2, further comprising a surface modifier bound to said poly(hydroxy acid) of said adjuvant microparticle.

### Claim 20 (depends on 3)

The immunogenic composition according to claim 3, further comprising a surface modifier bound to said poly(hydroxy acid) of said adjuvant microparticle.
